1.48
Precedente Chiudi:
$1.40
Aprire:
$1.4
Volume 24 ore:
436.04K
Relative Volume:
0.17
Capitalizzazione di mercato:
$161.00M
Reddito:
$100.56M
Utile/perdita netta:
$-119.05M
Rapporto P/E:
-1.2033
EPS:
-1.23
Flusso di cassa netto:
$-231.16M
1 W Prestazione:
+3.87%
1M Prestazione:
+18.95%
6M Prestazione:
+0.34%
1 anno Prestazione:
-20.70%
Alector Inc Stock (ALEC) Company Profile
Nome
Alector Inc
Settore
Industria
Telefono
415-231-5660
Indirizzo
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Confronta ALEC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ALEC
Alector Inc
|
1.475 | 152.81M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.21 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.84 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.53 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
850.07 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.65 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-10-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-10-22 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2024-12-17 | Downgrade | Mizuho | Outperform → Neutral |
| 2024-12-16 | Downgrade | Stifel | Buy → Hold |
| 2024-12-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Reiterato | H.C. Wainwright | Buy |
| 2024-11-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-09-25 | Iniziato | Goldman | Sell |
| 2023-09-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-09-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Iniziato | Mizuho | Buy |
| 2022-04-13 | Iniziato | Goldman | Sell |
| 2022-03-08 | Downgrade | Stifel | Buy → Hold |
| 2021-09-27 | Iniziato | William Blair | Outperform |
| 2021-01-15 | Ripresa | BofA Securities | Buy |
| 2020-06-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-28 | Iniziato | Goldman | Buy |
| 2020-03-06 | Iniziato | Citigroup | Buy |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-02-19 | Iniziato | Stifel | Buy |
| 2019-11-21 | Iniziato | BTIG Research | Buy |
| 2019-03-04 | Iniziato | Barclays | Overweight |
| 2019-03-04 | Iniziato | BofA/Merrill | Buy |
| 2019-03-04 | Iniziato | Morgan Stanley | Overweight |
| 2019-03-04 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Alector Inc Borsa (ALEC) Ultime notizie
What catalysts could drive Alector Inc. stock higherMarket Growth Review & AI Powered Trade Plan Recommendations - Улправда
Profit Review: How rising interest rates impact Alector Inc. stockShort Setup & Reliable Volume Spike Trade Alerts - Улправда
Will Alector Inc. stock split again soonJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - Улправда
What insider trading reveals about Alector Inc. stockJuly 2025 Opening Moves & Fast Gain Swing Alerts - ulpravda.ru
Alector appoints Neil Berkley as chief financial officer - MSN
Hedge Fund Bets: Can Alector Inc. stock sustain free cash flow growth2025 Stock Rankings & Reliable Entry Point Trade Alerts - Улправда
Will Alector Inc. stock outperform tech sector in 2025CEO Change & Daily Technical Forecast Reports - Улправда
Shareholders that lost money on Alector, Inc.(ALEC) should contact Levi & Korsinsky about Securities Fraud InvestigationALEC - ACCESS Newswire
Will Alector Inc. stock reach Wall Street targetsPortfolio Performance Report & High Conviction Buy Zone Alerts - DonanımHaber
Can Alector Inc. (0Z2) stock deliver strong annual returnsJuly 2025 Drop Watch & Smart Allocation Stock Tips - DonanımHaber
Is Alector Inc. stock a top momentum play2025 Bull vs Bear & Daily Technical Stock Forecast Reports - DonanımHaber
Options Flow: What catalysts could drive Alector Inc. stock higherJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда
Will Alector Inc. stock reach all time highs in 2025Bond Market & Fast Moving Stock Trade Plans - DonanımHaber
Will Alector Inc. stock deliver long term returnsJuly 2025 Technicals & Low Risk Growth Stock Ideas - Улправда
Investigation Alert: Alector, Inc. (ALEC) Under ScrutinyContact Levi & Korsinsky For Details - ACCESS Newswire
Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst (ALEC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Alector (ALEC) and Novan (NOVN) - The Globe and Mail
Alector (ALEC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Alector Appoints Neil Berkley as CFO - The Globe and Mail
How currency fluctuations impact Alector Inc stockMarket Trend Report & Expert Approved Momentum Trade Ideas - moha.gov.vn
Rate Cut: Is Alector Inc stock a safe investment in uncertain marketsTrade Entry Summary & Smart Swing Trading Techniques - moha.gov.vn
Alector (ALEC) Appoints Neil Berkley as CFO - GuruFocus
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer - The Manila Times
Alector, Inc. Appoints Neil Berkley as Chief Financial Officer - Quiver Quantitative
Alector (NASDAQ: ALEC) appoints Neil Berkley as chief financial officer - Stock Titan
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer | Associated Press | syndication news - Enidnews.com
Alector, Inc. Appoints Neil Berkley as Chief Financial Officer, Effective December 10, 2025 - marketscreener.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - MSN
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment - MSN
Is Alector Inc a good long term investmentTrading Psychology Tips & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Alector principal accounting officer Wong-Sarad sells $5,751 in stock By Investing.com - Investing.com South Africa
Alector principal accounting officer Wong-Sarad sells $5,751 in stock - Investing.com
Transcript : Alector, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 02 - marketscreener.com
Performance Recap: What valuation ratios show for Alector Inc 0Z2 stockStock Surge & Fast Entry Momentum Trade Alerts - moha.gov.vn
Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
How the Narrative Surrounding Alector Has Changed After the Latozinemab Trial Failure - Yahoo Finance
Will Alector Inc. (0Z2) stock announce special dividendTreasury Yields & AI Powered Market Entry Ideas - Newser
How supply shortages influence Alector Inc. (0Z2) stockQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - Newser
Arnon Rosenthal Sells 104,347 Shares of Alector (NASDAQ:ALEC) Stock - MarketBeat
Sara Kenkare-Mitra Sells 41,687 Shares of Alector (NASDAQ:ALEC) Stock - MarketBeat
What valuation ratios show for Alector Inc. (0Z2) stockTrade Signal Summary & Daily Technical Forecast Reports - Newser
How Alector Inc. (0Z2) stock compares with top peersBreakout Watch & High Yield Stock Recommendations - Newser
Will Alector Inc. (0Z2) stock benefit from Fed rate cutsWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
Alector CEO Rosenthal sells $116k in shares By Investing.com - Investing.com South Africa
Alector chief business officer sells $41,717 in stock By Investing.com - Investing.com South Africa
Alector principal accounting officer Wong-Sarad sells $9k in stock - Investing.com Canada
Alector: president Kenkare-Mitra sells $46k in shares By Investing.com - Investing.com Nigeria
Alector Inc Azioni (ALEC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):